The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Jul. 24, 8:21 AM

Slide #7. Enzymotec Secondary Offering

Company: Enzymotec (NASDAQ:ENZY)
Date announced: 2/13/2014
Shares Offered: 4,000,000
Secondary Offering Details: Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it has filed a registration statement on Form F-1 with the Securities and Exchange Commission for a proposed secondary public offering of 4,000,000 of its ordinary shares. The underwriters will have a 30-day option from the date of the offering to purchase up to an additional 600,000 ordinary shares. All of the shares will be offered by the Company's shareholders. The Company will not receive any proceeds from the sale of these shares.

Enzymotec is a nutritional ingredient and medical food company. Co.'s proprietary technologies, research expertise, and clinical validation process enable Co. to develop differentiated solutions across a variety of products. Co.'s innovative and diverse product suite addresses the entire human life-cycle - from infancy to old age - and is comprised of novel key ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor's supervision. Co. markets its product portfolio primarily to established global consumer companies and target large and growing consumer health and wellness markets.
Open the ENZY Page at The Online Investor »

Company Name:  Enzymotec Ltd.
Website:  www.enzymotec.com
Sector:  Biotechnology
Number of ETFs Holding ENZY:  3
Total Market Value Held by ETFs:  $233422
Total Market Capitalization:  $311.00M
% of Market Cap. Held by ETFs:  0.08%
 

Open the ENZY Page at The Online Investor (in a new window) »

July 24, 2014    8:21 AM Eastern
Quotes delayed 20 minutes



Buy (2.75 out of 4)
30th percentile
(ranked lower than approx. 70% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.